PRS 2015 01 Sykes
PRS 2015 01 Sykes
PRS 2015 01 Sykes
I
njection of facial fillers has been increasing
globally as new injectable products have been Disclosure: Dr. Solish is a consultant for Allergan and
developed and new applications have been Galderma and researcher for Allergan, Revance, Evo-
identified. The basis for successful filler injec- lus, and Merz. Dr. Jean Carruthers and Dr. Alastair
tions is a thorough knowledge of anatomy and Carruthers are consultants and researchers for Allergan
an understanding of the products to be injected. Pharmaceuticals, Merz USA, and Kythera Biopharma.
Knowledge of the applied anatomy can maximize Dr. Moradi serves as a consultant for Galderma. He
did not receive compensation for this article. Dr. Swift
is a consultant/clinical investigator for Allergan, Merz,
From Facial Plastic Surgery, University of California, Davis
Medical Center; Institute of Anatomy, Paracelsus Medical
and Galderma. Dr. Massry receives royalties from Else-
University Salzburg & Nuremberg; Expert2expert Group; vier and Springer. Dr. Sykes, Dr. Cotofana, Dr. Trevidic,
Department of Dermatology, University of Toronto; Depart- Dr. Lambros, and Dr. Remington have no financial in-
ment of Ophthalmology and Department of Dermatology, terest in any of the products, devices, or drugs mentioned
Faculty of Medicine, University of British Columbia; private in this article. Dr. Remington did not receive any finan-
practice; Westmount Institute of Plastic Surgery; Victoria cial aid or reimbursement or honorarium for the project.
Park MediSpa; St. Mary’s Hospital, McGill University;
Department of Ophthalmology, Keck School of Medicine,
University of Southern California; Beverly Hills Ophthalmic
Plastic and Reconstructive Surgery; Department of Plastic Supplemental digital content is available for this
Surgery, University of California, Irvine; and Remington article. Direct URL citations appear in the text;
Laser Dermatology Centre. simply type the URL address into any Web browser
Received for publication June 1, 2015; accepted August 6, to access this content. Clickable links to the mate-
2015. rial are provided in the HTML text of this article
Copyright © 2015 by the American Society of Plastic Surgeons on the Journal’s website (www.PRSJournal.com).
DOI: 10.1097/PRS.0000000000001830
204S www.PRSJournal.com
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
205S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
206S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
207S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
208S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
superficial to the pericranium (Figs. 9 and 10). a thorough knowledge of pertinent anatomy is
Loss of volume within this fat compartment con- required to maximize the efficiency of injection
tributes to deflation and descent of the tail of the and to minimize the incidence of complications.
brow and can create a deep sulcus of the upper
eyelid.8,9
REGIONAL APPROACHES
Augmentation of the lateral brow and upper
eyelid can enhance periorbital appearance. When Forehead
the filling agent is placed deep to the tail of the Nowell Solish, MD, FRCP; Toronto, Ontario,
brow, 3-dimensional brow correction including Canada
vertical lifting and horizontal brow projection is The shape and contour of the forehead is
achieved. The filler should be placed lateral to variable. Most consider an esthetically pleasing
the supraorbital neurovascular bundle (to avoid forehead to be round and smooth. Injectable fill-
injury) and deep to the orbicularis oculi muscle ers have become a much less invasive treatment
(Fig. 11). If the supraorbital notch can be pal- option for reshaping of the forehead.
pated, injection in the avascular subgaleal glide In my practice, I prefer to use HA fillers.
plane between the supraorbital and supratroch- They have the advantages of being moldable and
lear neurovascular bundles can be performed. reversible. I do not feel that any one product
Augmentation of the superior sulcus of is superior over another. I would suggest using
the upper eyelid can be accomplished with an one that has the ability to aid in projection of
injection just inferior to the supraorbital rim. the forehead. Typical examples for me include
Placement of HAG below the rim, deep to the Volift, Voluma, or Perlane, but many others can
orbicularis muscle, and superficial to the leva- be used.
tor aponeurosis can provide volume into a skel- Typically, the area to be injected is the mid
etonized orbit, improving the appearance of the forehead. At this level (mid forehead), the
upper eyelid. It is important to avoid injury to the supraorbital and supratrochlear vessels have
underlying septum orbitalis, upper eyelid fat pad,
become more superficial. To decrease the risk
and levator mechanism of the upper eyelid. These
of intravascular injection, the filler should be
structures should be deep and inferior to the area
placed at the level of the periosteum. At this
of injection.
level, one is likely to be underneath the ves-
sels. I am not sure how reliable aspiration is
Summary with a 30-gauge needle, but one can try to aspi-
Augmentation of the temple and periorbital rate before injecting to help decrease the risk
region can provide significant enhancement of of being intravascular. I prefer to use a tech-
the upper facial appearance. To accomplish this, nique where I inject small boluses of approxi-
mately 0.2 mL of filler across the forehead. The
boluses are placed like small tent poles in order
to increase the projection of the forehead. I
will gently mold the boluses to make sure that
the contour looks even. Typical volumes for me
are approximately 1 cc in total.
I use a syringe with a needle, I often transfer
my HA in to insulin syringes for control, but this
is a personal preference and is not necessary.
I use the B–D syringes with a 30 gauge needle,
which is similar in diameter to most needles that
are co-packed with the HA syringes. I do not
dilute my filler. I have no data to prove if there
is any disruption of the product through these
syringes but clinically have not noticed any dif-
Fig. 11. Left-sided cadaver dissection shown in a subgaleal dis- ference. Others prefer the use of a cannula in
section plane with the black arrow pointing to the supraorbital this area. I do not over inject this area, I use a
nerve and the red arrow pointing to the retroorbicularis oculi fat profile view to judge my endpoint and inject to
pad. The safe zone for injection of autologous fat of fillers is lat- full correction. (See Video, Supplemental Digi-
eral to the supraorbital neurovascular bundle. tal Content 2, which demonstrates Dr. Solish’s
209S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
210S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
211S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
The ramus frontalis branch of the superficial where the muscle fibers are sparse, remains rela-
temporal artery traverses the fossa in the deep tively avascular in that any terminal branches of
leaves of the superficial temporal fascia overly- the more posterior deep temporal vessels are of
ing the DTF on the muscle surface, anastomosing no relative consequence to injection. Inadvertent
more commonly with the ipsilateral supratroch- piercing of a more superficial artery or vein will
lear artery of the forehead. Superficial needle result in deposition of product deep to the vessel
injection of filler in this region should be avoided, on bone and should limit adverse events to pos-
as inadvertent intravascular injection into this sible bruising in the area. Again, in this region of
system of vessels can pass retrograde into the the fossa, it is mandatory to be close to the tempo-
ophthalmic artery causing central retinal artery ral fasciae lata (1 cm lateral), anterior (1 cm supe-
occlusion. The deep temporal arteries (anterior rior to the supraorbital rim), and absolutely deep
and posterior), branches of the second division of (the needle must be touching bone) to deposit
the internal maxillary artery, as well as the middle filler in this relatively avascular plane that is devoid
temporal artery, pass within the deep substance of any significant vessels. Maintaining the needle
of the muscle, diminishing in diameter as they on bone during the entire slow injection period is
ascend the fossa. A superficial plexus of veins, if fundamental for a safe outcome.
not apparent through the temporal skin, can be Using a product of significant G′ and cohe-
better visualized and marked once engorged by sivity, a vertical tent pole will be created that tra-
placing the head in a forward position. verses the thin fibers of the temporalis muscle in
Planned injection is a single puncture, verti- this region and then spreads between the DTF
cally oriented down to bone, 1 cm up the temporal and muscle creating a canopy effect, filling the
fusion line and 1 cm lateral, parallel to the supra- hollow. The product will spread circumferentially
orbital rim (one up, one over). (See Video, Sup- from the injection point, stopping at the fused
plemental Digital Content 5, which demonstrates fascia/bone interface of the tensor fasciae lata
Dr. Swift’s personal “one up, one over” technique and supraorbital rim but continuing inferiorly, as
to treat signs of aging in the temple hollows, avail- intended, toward the zygomatic arch. Placement
able in the “Related Videos” section of the full-text of an index finger posterior (behind) the injec-
article on PRSJournal.com or, for Ovid users, at tion point during injection will prevent the unde-
http://links.lww.com/PRS/B453.) Digital pressure sirable and irrelevant spread of product under
confirms the absence of a pulse at the injection the hair-bearing scalp. The author has found this
site, and any obvious veins are avoided. Aspira- technique to be the most economical, with typical
tion prior to injection is suggested, although the volumes of HA filler ranging from 0.25 to 0.75 cc
absence of blood reflux is not a guarantee of per temporal hollow. Withdrawal of the needle,
extravascular location of the needle tip. Main- which may have injured a deeper vessel (exter-
taining the tip of the needle on bone is crucial to nal sentinel vein), mandates gentle pressure for
avoiding inadvertent intravascular injection. This several minutes. This pressure is important in the
location, selected high up near the temporal crest absence of any obvious bleeding from the punc-
ture site, in order to avoid delayed ecchymosis.
Mild molding of product or gentle massage of the
temple posttreatment is occasionally indicated.
Superficial treatment of temporal hollows is
also possible with the use of a lower G′ product
through a blunt cannula, preferably in a direction
perpendicular to the superficial temporal arte-
rial branches. Sharp needle penetration into the
deeper portion of the temporal fossa above the
zygomatic arch is strictly contraindicated, due to
the presence of the branches of the second por-
tion of the internal maxillary artery, the emboliza-
tion of which has led to necrosis of the ipsilateral
Video 5. Supplemental Digital Content 5, demonstrating palate.
Dr. Swift’s personal “one up, one over” technique to treat signs of The aesthetic goal of temple fill in the female
aging in the temple hollows, is available in the “Related Videos” is to maintain a flat or slightly concave or convex
section of the full-text article on PRSJournal.com or, for Ovid curvature to the temple region. Obvious convexity
users, at http://links.lww.com/PRS/B453. signifies large muscle mass and is a masculinizing
212S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
Brows
Guy G. Massry, MD; Beverly Hills, Calif.
HAG can be used to lift the temporal brow10
and fill primary or secondary (postsurgical) upper
eyelid hollows.11,12 The author has found fewer
contour issues, blue color changes, and hydro-
philic reactions in the upper periorbita as com-
pared with its lower counterpart. This has allowed
a slightly more aggressive approach to injection as
more “room for error” may exist with eyebrow/
upper eyelid injections. This upper/lower eyelid
Video 6. Supplemental Digital Content 6, demonstrating discrepancy may be explained by assessing how
Dr. Moradi’s personal technique for temporal fossa volumiza- HAG fillers clinically behave in these distinct
tion using Restylane, is available in the “Related Videos” section locations. Recently, anatomic cadaveric studies
of the full-text article on PRSJournal.com or, for Ovid users, at of Juvederm injected deeply to the eyebrow and
http://links.lww.com/PRS/B454. infraorbital hollows have shown very different
213S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
patterns of migration of the gel after treatment. In over the backstop of the frontal bone, an elegant
the lower eyelid/cheek interface, the gel tends to way to improve contour and the overall result in
spread from deep to superficial and is present in general.12 Typically, 0.5–1 cc of filler is sufficient
multiple planes, while below the eyebrow it stays as more than subtle changes can look artificial.
deep, suggested to be impeded by fibrous septa Restylane is preferred here as its biophysical char-
within the brow fat pad.13,14 This may explain, in acteristics promote a 3-dimensional lift.
part, why edema, color, and contour changes are When addressing upper eyelid hollows, espe-
less frequently encountered in this site. cially after previous overresected blepharoplasty
Volumetric expansion of the subbrow tissue (A-frame deformity), the “lift, inject, massage”
is the principal behind filler-induced brow lift- technique described above is especially useful.12
ing. The author initially noted this potential years In the author’s experience, these combined
ago prior to injecting filler by observing the same maneuvers are more reliable and require less
effect when injecting local anesthetic during brow product than attempting to fill the eyelid hollow
lifting surgery. This has also been shown in the or “black hole” directly. After fill and “massage on
office setting.15 As with infraorbital hollow HAG bone,” when the lid returns to its native position,
filler injections, the skin is prepped, regional the contoured and smooth dispersion of the HAG
nerve blocks (lacrimal/supraorbital) are given, imparts a very natural appearance (Fig. 12). A half
and a cannula entry port is created just lateral cc of filler is often a good starting point in this sce-
to the outer brow. A 25-gauge 1½-inch cannula nario. As a general rule, avoid injecting the eyelid
is advanced parallel to the supraorbital rim just proper (below the rim) to prevent an inadvertent
above bone to an appropriate distance assessed alteration in lid position and function.12,15
clinically (typically to the hub of the cannula). Finally, the author recently described a normal
As shown in the accompanying video, after initial age-related depression at the nasal eyebrow/eye-
resistance from connective tissue elements (a pop lid transition, which has been called the “orbito-
is felt when penetrated), the cannula moves freely glabellar groove” related to its adjacent anatomic
in this plane without resistance. (See Video, Sup- structures.16 This periorbital hollow is continuous
plemental Digital Content 7, which demonstrates with the nasojugal groove (tear trough) at the
Dr. Massry’s personal technique for using HAG lower lid/cheek interface. Like in the infraorbital
filling for the brows, available in the “Related Vid- area, this depression can be effaced with small
eos” section of the full-text article on PRSJournal. amounts of 0.3–0.5 cc of filler. In this location, the
com or, for Ovid users, at http://links.lww.com/PRS/ author injects mid-depth (to avoid supraorbital
B455.) The gel is injected in a retrograde fashion vascular bundle) with adjunctive massage over the
after aspiration on the plunger. Lifting the brow rim for contour. This is the one area of the eye-
with the noninjecting hand elevates the subbrow brow/eyelid complex in which the author prefers
tissue above the orbital rim which more directly Beloteo as it is softer and less viscous.
and precisely expands this plane. The author has
found this, in combination with massage of the gel Val Lambros, MD, FACS; Newport Beach, Calif.
Eye movement tracking shows that when
people interact, the brows and periorbital areas
are among the most observed part of the face,
along with the mouth and perioral areas. These
are the most expressive parts of the face; a large
amount of meaning can be compressed into a
small geography; hence, small alterations in
these areas can make large differences in the
perceived facial information transmitted and
received. Experience shows that filling the brow
and upper lids can improve the look of the eyes
and periorbital area considerably. Here, a tech-
nique of filling the brow is described using HA
Video 7. Supplemental Digital Content 7, demonstrating fillers (Fig. 13).
Dr. Massry’s personal technique for using HAG filling for the Traditional blepharoplasty techniques, being
brows, is available in the “Related Videos” section of the full-text surgical, have relied on the things that surgery
article on PRSJournal.com or, for Ovid users, at http://links.lww. does best, removing skin and fat. Although there
com/PRS/B455. is a long history of successful patient treatments
214S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
Fig. 12. (Above, left) Post–upper blepharoplasty appearance of a woman with hollowed upper lids. (Above, right) Immediately after
fill with Restylane via “lift, inject, massage” technique on left. (Below, left) Immediately after fill with Restylane via “lift, inject, mas-
sage” technique on right. (Below, right) Final result at 6 weeks.
Lambros
doing traditional blepharoplasties, the procedure would seem to be safer to vasoconstrict them to
has its limitations. Being essentially a subtractive avoid arterial embolization. In addition, patients
procedure, the eyelids are defatted, the upper lids do not intuitively understand the idea of filling
become more hollow and defined and the bony the face; it is a visual concept and needs to be
orbit becomes visible. The answer is clearly to fill shown visually. I precede every brow injection
the orbit, but how? with a “local preview” in which about 1–2 cc of
At this time, injected fat is commonly used but local anesthetic with epinephrine is injected into
has some problems with reliability, overgrowth, the brow to demonstrate the intended result.
and irregularities that are difficult to correct. This is difficult to do without some experience,
For these reasons, we prefer the use of HA and the tendency is to make a blobby overfill of
fillers particularly in the brow. I think that it is a the upper lid which is not at all helpful. Small
finer brush than fat … one has more control over strings of local are placed and then massaged
the final contour than fat provides and can eas- into position. It takes a few minutes per eye. The
ily be reversed. The duration of injected HAs in patient is then shown the result and can make
the brow, as well as the temple and lower lid, is at his or her own decision about whether he or she
least 2 years in my experience and a duration of likes it. Patients like this process as it gives them
3–4 years is not uncommon. control over the result; it is like trying on clothes
Technique. before buying them. The location of the product
Although it might be idiosyncratic, I use local placement is in the subQ of the brow, deep to
anesthesia before all HA injection, not just for the orbicularis oculi but not on the periosteum
the numbing effect but for vasoconstriction— where the large vessels can be found. The injec-
there are large vessels in the superior orbit and it tion remains at or superior to the superior orbital
215S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
216S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Volume 136, Number 5S • Injectable Fillers in the Upper Face
217S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.
Plastic and Reconstructive Surgery • November Supplement 2015
ACKNOWLEDGMENTS significance of the temporal fat pad. Plast Reconstr Surg. 1989;83:
265–271.
Dr. Swift acknowledges Mondeal Aesthetics for the 6. Gonzales-Ulloa M, Costillo A, Stevens E, et al. Preliminary
video footage they released. The section “Applied Anat- study of the total restoration of the facial skin. Plast Reconstr
omy for Injectable Fillers: Upper Face and Temporal Surg. 1954;13:151.
Region” was written by Jonathan M. Sykes, MD, Sebas- 7. Goldberg RA, Wu JC, Jesmanowicz A, et al. Eyelid anat-
tian Cotofana, MD, PhD, and Patrick Trevidic, MD. omy revisited. Dynamic high-resolution magnetic reso-
nance images of Whitnall’s ligament and upper eyelid
The section “Regional Approaches” was written by Now- structures with the use of a surface coil. Arch Ophthalmol.
ell Solish, MD, FRCP, Jean Carruthers, MD, FRCSC, 1992;110:1598–1600.
FRC (OPHTH), Alastair Carruthers, MA, BM, BCh, 8. Hetzler L, Sykes J. The brow and forehead in periocular reju-
FRCPC, FRCP (Lon), Amir Moradi, MD, Arthur Swift, venation. Facial Plast Surg Clin North Am. 2010;18:375–384.
MD, CM, FRCS (C), Guy G. Massry, MD, Val Lam- 9. Javidnia H, Sykes J. Endoscopic brow lifts: have they replaced
coronal lifts? Facial Plast Surg Clin North Am. 2013;21:191–199.
bros, MD, FACS, B. Kent Remington, MD, FRCP. 10. Kornstein AN. Soft-tissue reconstruction of the brow with
Restylane. Plast Reconstr Surg. 2005;116:2017–2020.
11. Morley AM, Taban M, Malhotra R, et al. Use of hyaluronic
REFERENCES acid gel for upper eyelid filling and contouring. Ophthal Plast
1. Davidge KM, van Furth WR, Agur A, et al. Naming the soft Reconstr Surg. 2009;25:440–444.
tissue layers of the temporoparietal region: unifying ana- 12. Hartstein M, Massry G. Volumetric Rejuvenation of the
tomic terminology across surgical disciplines. Neurosurgery Hollow Superior Sulcus-the Final Frontier. 45th Fall Scientific
2010;67(3 Suppl Operative):ons120–ons129. Symposium of American Society of Ophthalmic Plastic and
2. Hussein S, Ascher G, Acland R. Surgical anatomy and blood Reconstructive Surgery, Chicago, Il.; October 16, 2014.
supply of the fascial layer of the temporal region. Plast 13. Griepentrog GJ, Lucarelli MJ. Anatomical position of hyal-
Reconstr Surg. 1976;77:17–24. uronic acid gel following injection to the eyebrow. Ophthal
3. Mitz V, Peyronie M. The superficial musculo-aponeurotic Plast Reconstr Surg. 2013;29:364–366.
system (SMAS) in the parotid and cheek area. Plast Reconstr 14. Griepentrog G, Lemke B, Burkat N, et al. Anatomical posi-
Surg. 1976;58:80–88. tion of hyaluronic acid gel following injection to the infraor-
4. Moss CJ, Mendelson BC, Taylor GI. Surgical anatomy of bital hollows. Opthal Plast Reonstr Surg. 2013;29:35–39.
the ligamentous attachments in the temple and periorbital 15. Lambros V. Volumizing the brow with hyaluronic acid fillers.
regions. Plast Reconstr Surg. 2000;105:1475–1490; discussion Aesthet Surg J. 2009;29:174–179.
1491. 16. Yoo DB, Peng GL, Massry GG. Effacing the orbitoglabel-
5. Stuzin JM, Wagstrom L, Kawamoto HK, et al. lar groove with transposed upper eyelid fat. Ophthal Plast
Anatomy of the frontal branch of the facial nerve: the Reconstr Surg. 2013;29:220–224.
218S
Copyright © 2015 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited.